BIOLASE Inc (NASDAQ:BIOL)
| 0.962 Delayed Data As of Jan 19 |  +0.132 / +15.85%Today’s Change | 0.21 Today|||52-Week Range 1.38 | +130.86% Year-to-Date |
Latest BIOL News | Press Releases
No recent news for BIOLASE Inc.
Today’s Trading
| Previous close | 0.83 |
| Today’s open | 0.88 |
| Day’s range | 0.82 - 0.99 |
| Volume | 53,745,937 |
| Average volume (3 months) | 16,361,837 |
| Market cap | $78.1M |
Data as of 7:54pm ET, 01/19/2021
Growth & Valuation
| Earnings growth (last year) | +26.36% |
| Earnings growth (this year) | +42.86% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -18.10% |
| P/E ratio | NM |
| Price/Sales | 0.34 |
| Price/Book | 69.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PDEXPro-Dex Inc | +1.33 | +4.63% |
| MLSSMilestone Scientific... | -0.11 | -3.99% |
| --Williamsville Sears ... | 0.00 | 0.00% |
| ---- |
Data as of 3:59pm ET, 01/19/2021
Financials
| Next reporting date | March 10, 2021 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $37.8M |
| Annual profit (last year) | -$17.9M |
| Net profit margin | -47.24% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
